Trophogen Top Navigation Element
About TrophogenAbout TrophogenAboutResearchTrophogen PressTrophogen EventsTrophogen's PublicationsCareersPublicationsContact TrophogenSite Map
Enhancing Nature Through Biotechnology
Enhancing Nature Through Biotechnology
FERTILITY THERAPEUTICS
In vitro ferilization technique showing single sperm being injected into the cytoplasm of an egg cell
Image of a single sperm being injected into the cytoplasm of an egg cell. Trophogen's unique technology should facilitate the treatment of infertility through in vitro fertilization techniques such as these.


Design of recombinant proteins with desired properties initially became possible in 1982 with the publishing of the first mutagenesis studies. In these past twenty years, however, successful examples of protein engineering have been rare. Our technology represents the first successful design of superactive analogs of glycoprotein hormones that shows major increases in bioactivity and far exceeds results shown for other protein ligands.


Partnering Opportunities. Potential investors.
  Line

Press Releass



Lead Product Candidates
1. FSH and LH superagonist for the treatment of human and animal infertility
2. TSH superagonist for enhancing 131 I diagnostic scanning and treatment of thyroid cancer
3. Labeled
TSHsuperagonist imaging agent for thyroid cancer
4.
TSH superagonist- radionuclide or –toxin for the targeted therapy of thyroid cancer
5.
LH and FSH superagonist- radionuclide or –toxin for the targeted therapy of ovarian cancer
6.
LH superagonist- radionuclide or –toxin for the targeted therapy of breast and prostate cancer
7. VEGF superagonist for therapeutic targeting of tumor vasculature, vascular imaging and as a media supplement for endothelial and stem cell proliferation/differentiation








Governor's Citation
AWARD CEREMONY


(read article about citation here)

 

 

Trophogen, Inc 2006
Home | About | Research | Press | Careers
Contact | Site Map